Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

71 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway
Cui S, Xia T, Zhao J, Ren X, Wu T, Kameni M, Guo X, He L, Guo J, Duperray-Susini A, Levillayer F, Collard JM, Zhong J, Pan L, Tangy F, Vidalain PO, Zhou D, Jiu Y, Faure M, Wei Y. Nat Commun. 2023 Dec 19;14(1):8440. doi: 10.1038/s41467-023-44201-2. PMID: 38114531
Located in Teams / VIDALAIN PO - VIRIMI / News
Generation of a C57BL/6J mouse strain expressing the CD45.1 epitope to improve hematopoietic stem cell engraftment and adoptive cell transfer experiments
Laubreton D, Djebali S, Angleraux C, Chain B, Dubois M, Henry F, Leverrier Y, Teixeira M, Markossian S, Marvel J.
Located in Teams / Marvel J - ICL / Actualités
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children
The New England Journal of Medicine ; S. Benezech, L. Khoryati, A. Belot
Located in Teams / Walzer T - LYACTS / Actualités
Antigen specific activation of cytotoxic CD8+ T cells by Staphylococcus aureus infected dendritic cells
Friot A, Djebali S, Valsesia S, Parroche P, Dubois M, Baude J, Vandenesch F, Marvel J, Leverrier Y.
Located in Teams / Marvel J - ICL / Actualités
Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells?
Front. Immunol.: Longet S. and Paul S. https://www.frontiersin.org/articles/10.3389/fimmu.2023.1216402/full
Located in Teams / Paul S - GIMAP / Actualités
Proof-of-Concept Human Organ-on-Chip Study: First Step of Platform to Assess Neuro-Immunological Communication Involved in Inflammatory Bowel Diseases
Int. J. Mol. Sci.: Gabriel-Segard T., Rontard J., Miny L., Dubuisson L., Batut A., Debis D., Gleyzes M., François F., Larramendy F., Soriano A., Honegger T. and Paul S. https://www.mdpi.com/1422-0067/24/13/10568
Located in Teams / Paul S - GIMAP / Actualités
Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations
Clinical Microbiology Reviews: Miguelena Chamorro B., De Luca K., Swaminathan G., Longet S., Mundt E., Paul S. https://journals.asm.org/doi/10.1128/cmr.00164-22
Located in Teams / Paul S - GIMAP / Actualités
Mucosal Vaccination with Live Attenuated Bordetella bronchiseptica Protects against Challenge in Wistar Rats
Vaccines: Miguelena Chamorro B., De Luca K., Swaminathan G., Rochereau N., Majorel J., Poulet H. Chanut B., Piney L., Mundt E., Paul S. https://www.mdpi.com/2076-393X/11/5/982
Located in Teams / Paul S - GIMAP / Actualités
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
Located in Teams / VIDALAIN PO - VIRIMI / News
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
Vaccines: Yaugel-Novoa M., Noailly B., Jospin F., Berger A.E., Waeckel L., Botelho-Nevers E., Longet S., Bourlet T., Paul S. https://www.mdpi.com/2076-393X/11/4/773
Located in Teams / Paul S - GIMAP / Actualités